Parkinson’s disease

FDA approves new drug for Parkinson’s disease

On March 21, the U.S. Food and Drug Administration (FDA) approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa…
statins parkinsons disease

Statins and Parkinson’s disease

Use of statins is associated with a higher risk for Parkinson’s disease, according to a study in Movement Disorders.  Objective Using a large U.S. claims database (MarketScan), we…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary cause of postpartum hemorrhage?